Clinical aspects of epidermodysplasia verruciformis and review of the literature

International Journal of Dermatology

Volumn 46, Issue 10, 2007, Pages 1069-1072

  Gül, Ülker ^a   Kiliç, Arzu ^a,b   Gönül, Müzeyyen ^a   Çakmak, Seray Külcü ^a   Bayis, Seçil Soylu ^a  

^a ANKARA TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHAN3 INTERFERON; ETRETIN; IMIQUIMOD;

ADULT; ARTICLE; CANCER RISK; CLINICAL ARTICLE; CLINICAL FEATURE; CONSANGUINEOUS MARRIAGE; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; MALE; MALIGNANT TRANSFORMATION; OCCUPATIONAL EXPOSURE; ONSET AGE; SCHOOL CHILD; SKIN BIOPSY; SKIN CANCER; SKIN MANIFESTATION; SQUAMOUS CELL CARCINOMA; SUN EXPOSURE; WART VIRUS;

ADOLESCENT; ADULT; CARCINOMA, SQUAMOUS CELL; CELL TRANSFORMATION, NEOPLASTIC; EPIDERMODYSPLASIA VERRUCIFORMIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; PAPILLOMAVIRUS INFECTIONS; RADIOTHERAPY; SKIN NEOPLASMS; SUNLIGHT;

EID: 34848865418     PISSN: 00119059     EISSN: 13654632     Source Type: Journal    
DOI: 10.1111/j.1365-4632.2006.03014.x     Document Type: Article

References (19)

1. Lowy DR, Androphy EJ. Warts. In: Freedberg IM, Eisen AZ, Wolff K, et al. 6th edn. New York: Mc Graw-Hill, 2003: 2119-2131.
2. Pereira de Oliveira WR, Carrasco S, Neto CF, et al. Nonspecific cell-mediated immunity in patients with epidermodysplasia verruciformis. J Dermatol 2003; 30: 203-209.
3. Oliveira WRP, Neto CF, Rady PL, et al. Clinical aspects of epidermodysplasia verruciformis. JEADV 2003; 17: 394-398.
4. Roncalli de Oliveira W, Neto CF, Rady PL, et al. Seborrheic keratosis-like lesions in patients with epidermodysplasia verruciformis. J Dermatol 2003; 30: 48-53.
5. Lane JA, Bowman PH, Cohen DJ. Epidermodysplasia verruciformis. South Med J 2003; 96: 613-615.
6. Sehgal VN, Luthra A, Bajaj P. Epidermodysplasia verruciformis: 14 members of a pedigree with an intriguing squamous cell carcinoma transformation. Int J Dermatol 2002; 41: 500-503.
7. Iraji F, Faghihi G. Epidermodysplasia verruciformis: Association with isolated Ig M deficiency and response to treatment with acitretin. Clin Exp Dermatol 2000; 25: 41-43.
8. Hu W, Nuovo G, Willen M, et al. Epidermodysplasia verruciformis in two half-brothers with HIV infection. J Cutan Med Surg 2004; 8: 357-360.
9. Haas N, Fuchs PG, Hermes B, et al. Remission of epidermodysplasia verruciformis-like skin eruption after highly active antiretroviral therapy in a human immunodeficiency virus-positive patient. Br J Dermatol 2001; 145: 667-690.
10. Garcia-Rio I, Garcia-F-Villalta MJ, Dauden E, et al. Epidermodysplasia verruciformis-like lesions in a patient with systemic lupus erythematosus. Acta Derm Venereol 2003; 83: 229-230.
11. Harwood CA, Surentheran T, McGregor JM, et al. Human papillomavirus infection and non-melanoma skin cancer in immunosuppressed and immunocompetent individuals. J Med Virol 2000; 61: 289-297.
12. Majewski S, Jablonska S. Why epidermodysplasia verruciformis - a rare genetic disease -has raised such great interest. Int J Dermatol 2004; 43: 309-311.
13. Jablonska S, Majewski S. Epidermodysplasia verruciformis: What's new? JEADV 2003; 17: 381-388.
14. Al Rubaie S, Breur J, Inshasi J, et al. Epidermodysplasia verruciformis with neurological manifestations. Int J Dermatol 1998; 37: 766-771.
15. Lutzner MA, Blanchet-Bardon C. Epidermodysplasia verruciformis. Curr Probl Derm 1985; 13: 164-185.
16. Anadolu R, Oskay T, Erdem C, et al. Treatment of epidermodysplasia verruciformis with a combination of acitretin and interferon α-2a. J Am Acad Dermatol 2001; 45: 269-269. 11.
17. Micali G, Nasca MR, Dall'Oglio F, et al. Cimetitidine therapy for epidermodysplasia verruciformis. J Am Acad Dermatol 2003; 48: S9-S10.
18. Oliveira WR, Neto CF, Rivitti EA. The lack of a clinical effect of cimetidine in the treatment of epidermodysplasia verruciformis. J Am Acad Dermatol 2004; 50: 14.
19. Hayashi J, Matsui C, Mitsuishi T, et al. Treatment of localized epidermodysplasia verruciformis with tacalcitol oinment. Int J Dermatol 2002; 41: 817-820.